Syra Health Corp. Class A Common Stock
Syra Health Corp., a healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education, and healthcare workforce in the United States. The company offers Syrenity, a behavioral and mental health application that identifies and prevents the progression of negative factors that can influence individuals' mental health by offering ta… Read more
Syra Health Corp. Class A Common Stock (SYRA) - Net Assets
Latest net assets as of September 2025: $2.21 Million USD
Based on the latest financial reports, Syra Health Corp. Class A Common Stock (SYRA) has net assets worth $2.21 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.26 Million) and total liabilities ($1.05 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $2.21 Million |
| % of Total Assets | 67.71% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 246.72 |
Syra Health Corp. Class A Common Stock - Net Assets Trend (2020–2024)
This chart illustrates how Syra Health Corp. Class A Common Stock's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Syra Health Corp. Class A Common Stock (2020–2024)
The table below shows the annual net assets of Syra Health Corp. Class A Common Stock from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $2.88 Million | -28.27% |
| 2023-12-31 | $4.01 Million | +465.16% |
| 2022-12-31 | $710.10K | +10035.61% |
| 2021-12-31 | $-7.15K | -71.51% |
| 2020-12-31 | $-4.17K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Syra Health Corp. Class A Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 881902600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $9.81K | 0.34% |
| Other Components | $11.69 Million | 406.21% |
| Total Equity | $2.88 Million | 100.00% |
Syra Health Corp. Class A Common Stock Competitors by Market Cap
The table below lists competitors of Syra Health Corp. Class A Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Stamper Oil & Gas Corp
PINK:STMGF
|
$1.15 Million |
|
Spectra7 Microsystems Inc
OTCQB:SPVNF
|
$1.15 Million |
|
Panther Metals Ltd
AU:PNT
|
$1.15 Million |
|
CF INDUSTRIES HLDG - Dusseldorf Stock Exchang
DU:C4F
|
$1.15 Million |
|
Shree Ram Proteins Limited
NSE:SRPL
|
$1.15 Million |
|
Apogee Minerals Ltd
V:APMI
|
$1.15 Million |
|
Carisma Therapeutics Inc.
NASDAQ:CARM
|
$1.15 Million |
|
ALTECH ADV.MAT. NA O.N.
F:AMA
|
$1.14 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Syra Health Corp. Class A Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 4,013,211 to 2,878,571, a change of -1,134,640 (-28.3%).
- Net loss of 3,759,238 reduced equity.
- New share issuances of 2,469,150 increased equity.
- Other factors increased equity by 155,448.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.76 Million | -130.59% |
| Share Issuances | $2.47 Million | +85.78% |
| Other Changes | $155.45K | +5.4% |
| Total Change | $- | -28.27% |
Book Value vs Market Value Analysis
This analysis compares Syra Health Corp. Class A Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.43x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $0.00 | $0.17 | x |
| 2021-12-31 | $0.00 | $0.17 | x |
| 2022-12-31 | $0.10 | $0.17 | x |
| 2023-12-31 | $0.82 | $0.17 | x |
| 2024-12-31 | $0.40 | $0.17 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Syra Health Corp. Class A Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -130.59%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -47.10%
- • Asset Turnover: 2.17x
- • Equity Multiplier: 1.28x
- Recent ROE (-130.59%) is below the historical average (-100.42%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.85K |
| 2021 | 0.00% | -0.23% | 2.63x | 0.00x | $-2.57K |
| 2022 | -298.29% | -37.71% | 2.42x | 3.27x | $-2.19 Million |
| 2023 | -73.22% | -53.28% | 1.12x | 1.23x | $-3.34 Million |
| 2024 | -130.59% | -47.10% | 2.17x | 1.28x | $-4.05 Million |
Industry Comparison
This section compares Syra Health Corp. Class A Common Stock's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $250,407,165
- Average return on equity (ROE) among peers: -38.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Syra Health Corp. Class A Common Stock (SYRA) | $2.21 Million | 0.00% | 0.48x | $1.15 Million |
| Addus HomeCare Corporation (ADUS) | $113.86 Million | 16.82% | 0.44x | $1.75 Billion |
| agilon health Inc (AGL) | $126.73 Million | -319.84% | 9.03x | $166.17 Million |
| Airsculpt Technologies Inc (AIRS) | $123.68 Million | 6.13% | 0.45x | $16.62 Million |
| Amedisys Inc (AMED) | $454.23 Million | -18.40% | 0.61x | $3.26 Billion |
| AMN Healthcare Services Inc (AMN) | $347.86 Million | 23.54% | 1.53x | $624.22 Million |
| American Shared Hospital Service (AMS) | $20.85 Million | 8.48% | 1.33x | $7.93 Million |
| American Oncology Network Inc. (AONC) | $226.04 Million | -0.05% | 0.10x | $112.23 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.08 Billion | 4.65% | 3.71x | $225.22 Million |
| Arem Pacific Corporation (ARPC) | $-45.09K | 0.00% | 0.00x | $246.12K |
| Astrana Health Inc (ASTH) | $8.55 Million | -109.27% | 1.29x | $1.08 Billion |